Am J Transplant, Volume 18, Suppl 3 Archives - Page 206 of 211 - ATC Abstracts

2018 American Transplant Congress
Benefit of Patient Portal Usage in Non-High Risk Kidney Transplant Recipients
A. Osband, J. Machan, P. Morrissey.
Surgery, Alpert Medical School of Brown University, Providence, RI.
Background: With widespread adoption of EHR (electronic health record), patients have access to a patient portal where they can view and thereby help monitor their…
2018 American Transplant Congress
Long-Term Follow-Up of Pediatric Kidney Recipients Who Received Alemtuzumab Induction
D. Harriman, A. Chen, J. Rogers, R. Stratta, G. Orlando, A. South, J-.J. Lin, A. Farney.
Surgery, Pediatrics, Cardiovascular Sciences Center, Wake Forest Baptist Medical Center, Winston-Salem, NC.
Introduction: Experience with alemtuzumab (alem) depleting antibody induction has rarely been studied in the pediatric population, and reports that exist have limited follow-up. The purpose…
2018 American Transplant Congress
The Role of Resilience in Healthcare Transitions among Adolescent and Young Adult Kidney Transplant Recipients
S. Quinn,¹ H. Fernandez,² T. McCorkle,¹ F. Barg,³ K. Ginsburg, R. Rogers,¹ S. Amaral.
¹Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; ²Medicine, Columbia University, New York, NY; ³Family Medicine and Community Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Adolescent and young adult (AYA) kidney transplant (KT) recipients experience high rates of premature allograft loss during healthcare transition (HCT). There is a critical need…
2018 American Transplant Congress
Adult-Sized Kidneys Transplanted into Infants and Small Children: Outcomes after Implementing Aggressive Fluid Regimen and Medications to Support Post-Transplant Perfusion
V. Sigurjonsdottir, P. Grimm, A. Chaudhuri.
Lucile Packard Children's Hospital, Palo Alto, CA.
Background: Risk of chronic graft ischemia secondary to hypoperfusion increases with greater disparity between donor and recipient size. At our center, the smallest recipients receive…
2018 American Transplant Congress
Prognostic Value and Biological Significances of Five Long Non-Coding RNAs in Hepatocellular Carcinoma
Y. Hou,¹ Z. Yu,² N. Tam,¹ S. Huang,¹ J. Yang,¹ L. Wu,¹ Y. Ma,¹ X. He.¹
¹Department of Organ Transplantation, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China; ²Laboratory of Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Objectives Increasing evidence suggests that long non-coding RNA (lncRNA) plays a vital role in metastasis and development in hepatocellular carcinoma (HCC). Tumor progression severely affect…
2018 American Transplant Congress
Locoregional Treatments before Liver Transplantation for Hepatocellular Carcinoma: A Cohort Study from the European Liver Transplant Registry
H-.C. Pommergaard, A. Rostved, R. Adam, L. Thygesen, M. Salizzoni, M. Bravo, D. Cherqui, P. De Simone, K. Boudjema, V. Mazzaferro, O. Soubrane, J. García-Valdecasas, J. Prous, A. Pinna, J. O'Grady, V. Karam, C. Duvoux, A. Rasmussen.
Rigshospitalet, Copenhagen, Denmark; Rigshospitalet, Copenhagen, Denmark; Hôpital Universitaire Paul Brousse, Villejuif, France; National Institute of Public Health, Copenhagen, Denmark; Molinette Hospital, Turin, Italy; Hospital Virgen del Rocio, Seville, Spain; Hôpital Universitaire Paul Brousse, Villejuif, France; University of Pisa Medical School Hospital, Pisa, Italy; Hôpital Pontchaillou, Rennes, France; Istituto Nazionale Tumori, Milan, Italy; Beaujon Hospital, Clichy, France; Hospital Clínic, Barcelona, Spain; Hospital Universitari de Bellvitge, Barcelona, Spain; S. Orsola Hospital, Bologna, Italy; King's College Hospital, London, United Kingdom; Hôpital Universitaire Paul Brousse, Villejuif, France; Henri Mondor Hospital, Créteil, France; Rigshospitalet, Copenhagen, Denmark.
PurposeLocoregional treatment while on the waiting list for liver transplantation (Ltx) for hepatocellular carcinoma (HCC) has shown to improve survival. However, effect of treatment types…
2018 American Transplant Congress
Analysis of Rabbit Anti-Thymocyte Globulin versus Basiliximab Induction in Pediatric Liver Transplant Recipients
D. Newland,¹ M. Royston,¹ D. McDonald,¹ K. Wallace-Boughter,² T. Németh,¹ K. Carlin,³ S. Horslen.²
¹Pharmacy, Seattle Children's Hospital, Seattle, WA; ²Pediatrics, UW School of Medicine, Seattle, WA; ³Seattle Children's Research Institute, Seattle.
Background: Literature is limited comparing rabbit anti-thymocyte globulin (rATG) versus basiliximab (BSX) induction in pediatric liver transplant (LT) recipients in the setting of modern-day maintenance…
2018 American Transplant Congress
The Impact of ABO Blood Type and Geography on Access to Lung Transplant
W. Tsuang, D. McMichael, X. Wang, M. Budev.
Cleveland Clinic, Cleveland.
Background: Rare blood types (B and AB) are increasingly a risk factor for lung transplant waitlist mortality when compared to common blood types (A and…
2018 American Transplant Congress
Evaluating Displays of Program Waitlist Mortality on Public Search Results
C. Schaffhausen,^1,4 M. Bruin,³ S. Chu,³ A. Matas,⁵ J. Lake,⁶ W. Kim,^7,4 S. Biggins,⁸ J. Snyder,^2,4 B. Kasiske,^1,4 A. Israni.^1,2,4
¹Department of Medicine, Hennepin County Medical Center (HCMC), University of Minnesota (UMN), Minneapolis, MN; ²Department of Epidemiology and Community Health, UMN, Minneapolis, MN; ³College of Design, UMN, Minneapolis, MN; ⁴Scientific Registry of Transplant Recipients, Minneapolis Medial Research Foundation, Minneapolis, MN; ⁵Department of Surgery, UMN, Minneapolis, MN; ⁶Division of Gastroenterology, Hepatology, and Nutrition, UMN, Minneapolis, MN; ⁷Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, CA; ⁸Division of Hepatology, University of Washington, Seattle, WA.
The Scientific Registry of Transplant Recipients (SRTR) provides federally mandated program-specific transplant data to the public. SRTR has developed new website materials to provide more…
2018 American Transplant Congress
Patient-Researcher Partnership Platform within the Canadian National Transplant Research Program: The First Year Experience
M-.C. Fortin,^2,3,6 S. Bédard,^1,2 J. Allard,^2,3 F. Ballesteros,^2,3 S. Anthony,^2,4,5 A. Boivin,^1,3 A. Lespérance,^1,3 D. Hartell.²
¹Centre of Excellence for Partnership with Patients and the Public, Montreal, Canada; ²Canadian National Transplant Research Program, Ottawa, Canada; ³Centre de Recherche du CHUM, Montreal, Canada; ⁴Factor-Inwentash Faculty of Social Work, University of Toronto, Toronto, Canada; ⁵The Hospital for Sick Children, Toronto, Canada; ⁶Transplant and Nephrology Division, Centre Hospitalier de l'Universite de Montreal, Montreal, Canada.
Background: Patients have unique expertise in the diseases they deal with. The Canadian National Transplant Research Program (CNTRP) is a research initiative that aims to…